Polynucleotide encoding a genetically engineered P30 antigen

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C536S023100

Reexamination Certificate

active

11316532

ABSTRACT:
The present invention relates to a genetically engineered P30 antigen and a combination or mixture of antigens (e.g., the genetically engineered P30 antigen and P35) that may be used in the detection of IgM and/or IgG antibodies toToxoplasma gondii. Furthermore, the present invention also relates to methods of using this genetically engineered P30 antigen and combination of antigens, antibodies raised against this genetically engineered P30 antigen and combination of antigens, as well as kits and vaccines containing the genetically engineered P30 antigen and antigens present in the combination.

REFERENCES:
patent: 6329157 (2001-12-01), Maine et al.
patent: 6372443 (2002-04-01), Jacobs et al.
patent: WO96/02654 (1996-02-01), None
patent: 99/61906 (1999-12-01), None
patent: WO99/66043 (1999-12-01), None
He, et al., Nature Structural Biology, “Structure of the immunodominant surface antigen from the Toxoplasma gondii SRS superfamily.” 9(8), 606-611, (2002).
Huskinson, et al., Journal of Clinical Microbiology, “Toxoplasma antigens recognized by human immunoglobulin a antibodies”, 28(12), 2632-2636 (1990).
Kim, et al., Infection and Immunity, American Society for Microbiology, “Conformationally appropriate expression of the Toxoplasma antigen SAG1 (p30) in CHO cells” 62(1) 203-209 (1994).
Nam, et al., Korean Journal of Parasitology, “Analysis of antigenic domain of GST fused Major Surface protein (p30) fragments of Toxoplasma gondii”, 34(2), 135-141 (1996).
Remington, J.S., et al.,Infectious Diseases of the Fetus and Newborn Infant, Fourth Edition, “Toxoplasmosis”, J.S. Remington and J.O. Klein, Eds., pp. 140-267, Saunders, Philadelphia (1995).
Sabin, A.B. et al.,Science, “Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasiste (Toxoplasma)”, vol. 108, pp. 660-663 (1948).
Jacobs, L., et al.,J. Parasitol, “A Hemagglutination Test for Toxoplasmosis”, vol. 43, pp. 308-314 (1957).
Walton, B.C. et al.,Am. J. Trop. Med. Hyg. , “Comparison of the Indirect Fluorescent Antibody Test and Methylene Blue Dye Test for Detection of Antibodies to Toxoplasma Gondii”, vol. 15, pp. 149-152 (1966).
Naot, Y. et al.,J. Infect. Dis. , Án Enzyme-Linked Immunosorbent Assay for Detection of IgM Antibodies to Toxoplasma Gondii: Use for Diagnosis of Acute Acquired Toxoplasmosis, 142, pp. 757-766 (1980).
Prince, et al.,Mol. Biochem. Parasito, “Cloining Expression, and cDNA Sequence of Surface Antigen P22 from Toxoplasma Gondii”, vol. 43, pp. 97-106 (1990).
Cesbron-Delauw, et al.,Proc. Nat. Acad. Sci. , “Molecular characterization of a 23-Kilodalton Major Antigen Secreted by Toxoplasma Gondii”, vol. 86, pp. 7537-7541 (1989).
Johnson, et al.,Gene, “Cloning of Toxoplasma Gondii Gene Fragments Encoding Diagnostic Antigens”, vol. 99, pp. 127-132 (1991).
Prince, et al.,Mol. Biochem. Parasiotol, “Cloning of cDNAs Encloding a 28 Kilodalton Antigen of Toxoplasma Gondii”, vol. 34, pp. 3-13 (1989).
Bonhomme, et al.,J. Histochem. Cytochem, “Quantitative Immunolocalization of a P29 Protein (GRA7), a New Antigen of Toxoplasma Gondii”, vol. 46, pp. 1411-1421 (1998).
Burg, et al.,J. Immunol., “Molecular Analysis of the Gen Encoding the major Surave Antigen of Toxoplasma Gondii”, vol. 141, pp. 3584-3591 (1998).
Mevelec, et al.,Mol. Biochem. Parasitol., “Molecular Cloning of GRA4, a Toxoplasma Gondii Dense Granule Protein, Recongnized by Mucosal IgA Antibodies”, vol. 56, pp. 227-238 (1992).
Saavedra, et al.,J. Immunol. , “Human T Cell Clone Identifies A Potentially Protective 54-kDa Protein Antigen of Toxoplasma Gondii Cloned and Expressed inExcherichia coli”, vol. 147, pp. 1975-1982 (1991).
Safford, et al.,J. Clin. Pathol. , “Automated Microparticle Enzyme Immunoassays for IgG and IgM Antibodies to Toxoplasma Gondii”, 44:238-242 (1991).
Kapust and Waugh,Protein Science , “Escherichia coliMaltose-Binding Protein is Uncommonly Effective at Promoting the Solubility of Polypeptides To Which It Is Fused”, 8, 1668-1674 (1991).
Robinson, et al.,J. Clin. Microbiol., “Analysis of the Humoral Response to the Flagellin Protein of Borrelia Burgdorferi: Cloning of Regions Capable of Differentiating Lyme Disease from Syphilis”, 31:629-635 (1993).
Velge-Roussel, et al.,Molec. Biochem. Parasitol, “Epitopic Analysis of the Toxoplasma Gondii Major Surface Antigen SAG1”, 66:31-38 (1994).
Desomonts, G. and Remington, J.S.,J. Clin. Microbiol., “Direct Agglutination Test for Diagnosis of Toxoplasma Infection: Method for Increasing Sensitivity and Specificity”, 11 :562-568 (1980).
Pouletty, et al.J. Immunol. Methods, “An Anti-human u Chain Monoclonal Antibody: Use for Detection of IgM Antibodies to Toxoplasma Gondii by Reverse Immunosorbent Assay”, 76:289-298 (1985).
Zweig, HM,Clin. Chem. , “Receiver-Operating Characteristic (ROC) Plots: A Fundamental Evaluation Tool in Clinical Medicine”, 39:561-577 (1993).
New England Biolabs, Inc. 1998/99 Catalog, pp. 136-137.
Gerhold, et al.,BioEssays, vol. 18, No. 12, pp. 973-981 (1996).
Wells, et al,Journal of Leukocyte Biology, vol. 61, No. 5, pp. 545-550 (1997).
Russell, et al.,Journal of Molecular Biology, vol. 244, pp. 332-350 (1994).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polynucleotide encoding a genetically engineered P30 antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polynucleotide encoding a genetically engineered P30 antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotide encoding a genetically engineered P30 antigen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3951607

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.